Silibinin: where is the ethical conundrum?

Chest. 2015 Mar;147(3):e105. doi: 10.1378/chest.14-2682.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acute Kidney Injury / drug therapy*
  • Antioxidants / therapeutic use*
  • Humans
  • Liver Failure, Acute / drug therapy*
  • Male
  • Mushroom Poisoning / drug therapy*
  • Silymarin / therapeutic use*

Substances

  • Antioxidants
  • Silymarin